Oral pharmaceutical formulation in the form of aqueous suspension for modified release of active principle(s)

A suspension of microcapsules in an aqueous liquid phase that allows modified release of at least one active principle and is intended for oral administration, wherein said suspension comprises a plurality of microcapsules and an aqueous liquid phase,

• wherein the aqueous liquid phase is saturated or becomes saturated with active principle(s) on contact with the microcapsules, and
• wherein each microcapsule comprises
• (a) a core comprising at least one active principle(s), wherein none of the at least one active principle(s) is amoxicillin and
• (b) a film coating that:
• (i) is applied to the core, (ii) controls the modified release of the active principle(s) in gastrointestinal tract fluids, and (iii) comprises:
• (1) at least one film-forming polymer (P1) insoluble in gastrointestinal tract fluids, present in an amount of 50 to 90% by dry weight based on the total weight of the coating composition, and wherein at least one of said at least one film-forming polymer (P1) is a water-insoluble cellulose derivative;
• (2) at least one nitrogen-containing polymer (P2) present in an amount of 2 to 25% by dry weight based on the total weight of the coating composition, and wherein at least one of said at least one nitrogen-containing polymer (P2) is selected from the group consisting of:
• polyacrylamide, poly-N-vinylamide, and poly-N-vinyllactam;
• (3) at least one plasticizer present in an amount of 2 to 20% by dry weight based on the total weight of the coating composition, and wherein at least one of said at least one plasticizer is selected from the group consisting of:
• glycerol esters, phthalates, citrates, sebacates, cetyl alcohol esters, and castor oil;
• and
• (4) at least one surfactant or lubricant present in an amount of 2 to 20% by dry weight based on the total weight of the coating composition, and wherein at least one of said at least one surfactant or lubricant is selected from the group consisting of:
• anionic surfactants, non-ionic surfactants, and lubricants, and mixtures thereof;
• and wherein the in vitro release profile of the suspension of microcapsules in an aqueous liquid phase on day ten is similar to the release profile on day zero, as measured using a type II apparatus according to the European Pharmacopoeia 3rd edition, in a phosphate buffer medium of pH 6.8, at a temperature of 37° C.